Format

Send to

Choose Destination
J Vasc Interv Radiol. 2011 Dec;22(12):1693-6. doi: 10.1016/j.jvir.2011.09.014. Epub 2011 Oct 27.

The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011.

Author information

1
University of Colorado, Department of Radiology, Aurora, CO 80045, USA. Charles.ray@ucdenver.edu

Abstract

This commentary is written in response to a recent Cochrane Collaboration review published in March 2011 (1). The authors of this commentary would like to express their concerns over the conclusions of the Cochrane review, which state, "There is no firm evidence to support or refute transarterial chemoembolization (TACE) or transarterial embolization (TAE) for patients with unresectable hepatocellular carcinoma (HCC)."

PMID:
22035882
PMCID:
PMC4332810
DOI:
10.1016/j.jvir.2011.09.014
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center